Introduction
Melanocortin peptides represent a fascinating class of compounds with diverse biological activity spanning pigmentation, sexual function, appetite regulation, and inflammation. Their primary mechanism involves agonism at melanocortin receptors (MC1R–MC5R), which are distributed across skin, brain, adrenal glands, and immune cells. This article focuses specifically on compounds studied in the context of melanogenesis and pigmentation biology.
For research and laboratory use only. Not intended for human or veterinary administration.
The Melanocortin System
Melanocortin receptors are G protein-coupled receptors activated by peptides derived from pro-opiomelanocortin (POMC), including α-MSH, β-MSH, and ACTH. In the skin, MC1R is the primary receptor expressed on melanocytes, where its activation stimulates the production of eumelanin (brown/black pigment) over phaeomelanin (red/yellow pigment). Eumelanin provides significantly greater photoprotection against UV-induced DNA damage.
Key Research Compounds
Melanotan I (Afamelanotide)
A linear analogue of α-MSH with selective agonism at MC1R. Melanotan I has been studied extensively for its ability to stimulate melanogenesis in melanocyte models and in vivo, increasing eumelanin production and providing a degree of photoprotection. Research has also explored its potential in erythropoietic protoporphyria (EPP) models, where photoprotection is of clinical relevance. Its selectivity for MC1R results in a cleaner pharmacological profile compared to Melanotan II.
Melanotan II
A cyclic analogue of α-MSH with broader melanocortin receptor activity (MC1R, MC3R, MC4R, MC5R). Melanotan II produces potent melanogenic effects via MC1R while also activating MC4R in the hypothalamus, which has led to research into appetite suppression and sexual function. Its broader receptor profile makes it a valuable tool for investigating melanocortin receptor pharmacology across multiple systems simultaneously. Research applications include pigmentation biology, obesity models, and sexual function research.
PT-141 (Bremelanotide)
A cyclic heptapeptide derived from Melanotan II, with the primary distinction that it lacks the melanogenic activity of its parent compound. PT-141 acts predominantly at MC4R and MC3R, making it a selective tool for investigating central melanocortin signalling without confounding pigmentation effects. Research has focused on its role in sexual function models through hypothalamic MC4R activation.
Melanogenesis: The Research Pathway
MC1R activation triggers a cAMP-mediated signalling cascade that upregulates MITF (microphthalmia-associated transcription factor), the master regulator of melanocyte biology. MITF drives expression of key melanogenic enzymes including tyrosinase, TRP-1, and TRP-2, ultimately increasing eumelanin synthesis. Research into this pathway has implications for understanding photoprotection, vitiligo, and melanoma biology.
Research Applications
- Melanogenesis and melanocyte receptor pharmacology
- UV photoprotection and DNA damage prevention models
- Vitiligo and pigmentation disorder research
- Melanoma biology and MC1R signalling
- Appetite regulation and energy homeostasis (MC3R/MC4R)
- Sexual function and hypothalamic melanocortin signalling
Storage and Handling
Store lyophilised melanocortin peptides at −20°C. Reconstitute with bacteriostatic water. Once reconstituted, store at 2–8°C and use within 28 days. Protect from light, as melanocortin peptides are sensitive to UV degradation.
All products supplied by Vanta Labs are intended strictly for laboratory and research purposes.